Paroxetine Tablet, Film Coated
Product Images NDC 85534-0026

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Paroxetine (NDC 85534-0026). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Hawaii Repack, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image (3dbda37c 9453 474f A247 Fceb50497ae8 01)

Image (3dbda37c 9453 474f A247 Fceb50497ae8 01)
Chemical structure diagram showing the molecular structure of Paroxetine, including aromatic rings, fluorine (F), and oxygen-containing groups, along with a hydrochloride (HCl) moiety.*
FDA Label Image

Image (3dbda37c 9453 474f A247 Fceb50497ae8 02)

Image (3dbda37c 9453 474f A247 Fceb50497ae8 02)
A chart depicting fold change and 90% confidence intervals for various interacting drugs relative to reference values. It shows changes in Cmax and AUC for Pimozide 2 mg, Desipramine 100 mg, Propranolol 80 mg twice daily, Digoxin 0.25 mg once daily, and Phenytoin 300 mg, presented as points with horizontal lines indicating confidence intervals on a logarithmic scale.*
FDA Label Image

Image (3dbda37c 9453 474f A247 Fceb50497ae8 03)

Image (3dbda37c 9453 474f A247 Fceb50497ae8 03)
A chart showing the pharmacokinetic interactions of Paroxetine with various drugs including Cimetidine, Phenobarbital, Phenytoin, Digoxin, and Diazepam. It plots fold change and 90% confidence intervals for Cmax and AUC parameters, indicating changes relative to a reference standard.*
FDA Label Image

Image (3dbda37c 9453 474f A247 Fceb50497ae8 04)

Image (3dbda37c 9453 474f A247 Fceb50497ae8 04)
A chart showing the fold change and 90% confidence intervals in pharmacokinetic parameters (Cmax, AUC, Cmin) of Paroxetine across different populations, including varying degrees of renal and hepatic impairment, age groups over 65 with different doses, and gender (males). The x-axis measures change relative to reference on a logarithmic scale from 0.5 to 50.*
FDA Label Image

Image Description (Label)

Image Description (Label)
Labels for Paroxetine Tablets USP 10 mg oral film-coated tablets distributed by Hawaii Repack, with NDC codes 85534-0026-0, 85534-0026-1, 85534-0026-2, and 85534-0026-3 indicating quantities of 30, 60, 90, and 120 tablets respectively. Distributed by Zydus Pharmaceuticals (USA) Inc. Labels include storage instructions and federal dispensing cautions.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.